Organization · Venture Capital
Seido Capital
Seido Capital is a Montreal-based venture capital firm focused on early and growth stage investments in life sciences and deep tech across North America. The firm emphasizes biotechnology, medical devices, and AI tools for the life sciences sector.
Overview
What Seido Capital does
What Seido Capital is
Seido Capital is a Montreal-based venture capital firm focused on early and growth stage investments in life sciences and deep tech across North America. The firm emphasizes biotechnology, medical devices, and AI tools for the life sciences sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Seido Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Seido Capital as a funder
Investment thesis
Seido Capital focuses on life sciences and deep tech, investing in innovative companies from pre-seed to IPO, with a strong emphasis on biotechnology and medical devices.
Focus narrative
Seido Capital invests in life sciences and deep tech companies at various stages, from pre-seed to IPO. Their investment strategy emphasizes sectors such as biotech, medical devices, diagnostics, and digital health tools. The firm aims to empower pioneering technologies and data-driven solutions, leveraging cross-border partnerships to ensure sustainable growth.
Value beyond capital
Seido Capital provides not only capital but also strategic guidance and expertise to its portfolio companies, helping them navigate the complexities of the life sciences and deep tech sectors. The firm emphasizes strong exit pathways from the outset, ensuring that companies are well-positioned for future growth and success.
Terms and economics
- Typical check
- $500,000–$2,500,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Ipo
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Seido Capital's portfolio includes companies involved in cutting-edge diagnostics, digital therapeutics, and transformative AI technologies. Specific names and descriptions of portfolio companies were not provided.
Common questions
What to know about Seido Capital
Upseed classifies Seido Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.